Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maryse Tardieu"'
Autor:
Stéphanie Senectaire, Anne-Françoise Sapin, Thomas Sinegre, Alexandre Trapani, Virginie Fourneyron, Aurélien Lebreton, Adeline Trayaud, Laurie Talon, Aurélie Vaissade, Maxence Tillier, Maryse Tardieu
Publikováno v:
Annales de biologie clinique. 78(6)
Exploring coagulation in newborns and children is a challenge due to the low levels of both procoagulant factors and inhibitors. Conventional coagulation tests might be inadequate to explore all of these changes. The aim of the study is to evaluate t
Autor:
Marc G. Berger, Maxence Tillier, Aurélie Vaissade, Anne‐Lise Barbin, Thomas Sinegre, Maryse Tardieu, Laurie Talon, Stéphanie Senectaire, Virginie Fourneyron, Aurélien Lebreton, Piotr Gembara, Adeline Trayaud
Publikováno v:
Haemophilia
Haemophilia, Wiley, 2020, 26 (3), pp.543-552. ⟨10.1111/hae.14003⟩
Haemophilia, Wiley, 2020, 26 (3), pp.543-552. ⟨10.1111/hae.14003⟩
International audience; Introduction Recombinant factor IX Fc fusion protein (rFIXFc) is an extended half-life concentrate for the treatment of haemophilia B (HB). rFIXFc activity monitoring is crucial in several clinical situations. However, differe
Autor:
Adeline Trayaud, Maryse Tardieu, Aurélien Lebreton, Laurie Talon, Thomas Sinegre, Aurélie Vaissade
Publikováno v:
Blood. 132:5016-5016
rFIX-Fc is an extended half-life (EHL) recombinant FIX concentrate approved for the prophylaxis and treatment of bleeding events in haemophilia B. A high laboratory and reagent-specific variability is described for rFIX-Fc activity measurements, over